These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

54 related items for PubMed ID: 2079473

  • 1. Gemfibrozil in familial and type V hyperlipidaemias. Report of 3 cases.
    Varthakavi P, Turakhia DP, Sharma S, Salgaonkar DS, Nihalani KD, Joshi VR.
    J Assoc Physicians India; 1990 Nov; 38(11):860-2. PubMed ID: 2079473
    [Abstract] [Full Text] [Related]

  • 2. Gemfibrozil in hyperlipidaemia: an open, single blind trial.
    Varthakavi PK, Turakhia DP, Sharma SS, Salgaonkar DS, Nihalani KD, Joshi VR.
    J Assoc Physicians India; 1990 Feb; 38(2):136-40. PubMed ID: 2380132
    [Abstract] [Full Text] [Related]

  • 3. Long-term effect of gemfibrozil on coronary heart disease risk profile of patients with primary combined hyperlipidaemia.
    Athyros VG, Papageorgiou AA, Avramidis MJ, Kontopoulos AG.
    Coron Artery Dis; 1995 Mar; 6(3):251-6. PubMed ID: 7788039
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of combined hyperlipidemia with lovastatin versus gemfibrozil: a comparison study.
    Ojala JP, Helve E, Tikkanen MJ.
    Cardiology; 1990 Mar; 77 Suppl 4():39-49. PubMed ID: 2073671
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The recognition and management of hyperlipidaemia in adults: A policy statement of the European Atherosclerosis Society.
    Eur Heart J; 1988 May; 9(5):571-600. PubMed ID: 3402474
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Lipid therapy in risk patients. Do we concentrate too much on LDL cholesterol?].
    März W.
    MMW Fortschr Med; 2005 Apr 07; 147(14):14. PubMed ID: 15887675
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of gemfibrozil treatment on vascular reactivity of streptozotocin-diabetic rat aorta.
    Ozansoy G, Akin FB.
    J Pharm Pharmacol; 2004 Feb 07; 56(2):241-6. PubMed ID: 15005883
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increased susceptibility of LDL to in vitro oxidation in patients with insulin-dependent and non-insulin-dependent diabetes mellitus.
    Cominacini L, Garbin U, Pastorino AM, Fratta Pasini A, Campagnola M, De Santis A, Davoli A, Lo Cascio V.
    Diabetes Res; 1994 Feb 07; 26(4):173-84. PubMed ID: 7648791
    [Abstract] [Full Text] [Related]

  • 17. Gemfibrozil in familial combined hyperlipidaemia: effect of added low-dose cholestyramine on plasma and biliary lipids.
    Odman B, Ericsson S, Lindmark M, Berglund L, Angelin B.
    Eur J Clin Invest; 1991 Jun 07; 21(3):344-9. PubMed ID: 1909637
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Non-symmetric subcutaneous lipomatosis associated with familial combined hyperlipidaemia.
    Rubinstein A, Goor Y, Gazit E, Cabili S.
    Br J Dermatol; 1989 May 07; 120(5):689-94. PubMed ID: 2757931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.